In certain inherited metabolic disorders, the absence of a functional enzyme can result in toxic accumulation of its substrate throughout the body. Often however, toxicity is manifest only in certain organs or tissues. in one such example, an adenosine deaminase deficiency results in the accumulation of (deoxy)adenosine substrate which is toxic for T and B cells. Nonetheless, this disorder is amenable to Current gene therapy approaches because peripheral lymphocytes and marrow progenitor cells can be targeted for gene transfer with the normal gene. in contrast, in a second example, where ornithine aminotransferase is deficient, ornithine accumulates and is toxic to retinal pigment epithelial cells. However, no realistic way exists at the present time to transfer the normal allele to these cells in humans. In this proposal we will test a new method of gene therapy applicable to both kinds of disorders. This is possible by focusing on reducing the systemic accumulation of a toxic enzyme substrate. Specifically, the approach is to create an intracellular enzyme sink in a patch of autologous skin which metabolizes the circulating precursor and thus reduces the systemic load. Keratinocytes and fibroblasts cultured from an enzyme deficient donor will receive the missing gene by ex vivo transfer and be used in the construction of transplantable organotypic cultures. Two specific disease models will be tested, severe combined immunodeficiency caused by adenosine deaminase deficiency and gyrate atrophy caused by ornithine aminotransferase deficiency.
The specific aims i nclude (i) a proof of concept in athymic mice; (ii) a quantitative assessment of substrate metabolism by genetically modified skin using an organotypic culture model; and (iii) an evaluation of methods designed to circumvent the loss of gene expression that is known to occur following transplantation of genetically modified cells to animal hosts. The information gained from this research will permit an accurate assessment of cutaneous gene therapy for reducing substrate loads in inherited metabolic disorders and will provide the basis for clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK049093-02
Application #
2149681
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1994-09-30
Project End
1999-08-31
Budget Start
1995-09-01
Budget End
1996-08-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Dentistry
Type
Schools of Dentistry
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Sandalon, Z; Fusenig, N E; McCutcheon, J et al. (2001) Suicide gene therapy for premalignant disease: a new strategy for the treatment of intraepithelial neoplasia. Gene Ther 8:232-8
Ghazizadeh, S; Harrington, R; Taichman, L (1999) In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy. Gene Ther 6:1267-75
Ghazizadeh, S; Harrington, R; Garfield, J et al. (1998) Retrovirus-mediated transduction of porcine keratinocytes in organ culture. J Invest Dermatol 111:492-6
Kolodka, T M; Garlick, J A; Taichman, L B (1998) Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc Natl Acad Sci U S A 95:4356-61
Sullivan, D M; Jensen, T G; Taichman, L B et al. (1997) Ornithine-delta-aminotransferase expression and ornithine metabolism in cultured epidermal keratinocytes: toward metabolic sink therapy for gyrate atrophy. Gene Ther 4:1036-44
Jensen, T G; Sullivan, D M; Morgan, R A et al. (1997) Retrovirus-mediated gene transfer of ornithine-delta-aminotransferase into keratinocytes from gyrate atrophy patients. Hum Gene Ther 8:2125-32
Ghazizadeh, S; Carroll, J M; Taichman, L B (1997) Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy. J Virol 71:9163-9
Fenjves, E S; Yao, S N; Kurachi, K et al. (1996) Loss of expression of a retrovirus-transduced gene in human keratinocytes. J Invest Dermatol 106:576-8